| HOME >> BIOLOGY >> TECHNOLOGY |
Cash provided by (used in):
Operating activities:
Loss for the period (2,761,874) (1,469,728) (29,581,295)
Items not involving cash:
Amortization of:
Property and equipment 108,151 85,426 1,163,788
Deferred costs - 14,364 55,055
Leasehold inducements (10,371) - (45,781)
Loss on disposal of equipment - - 23,532
Write-off of leasehold
improvements - - 86,349
Leasehold inducement - - 89,148
Non-cash stock-based
compensation 266,197 31,456 1,486,216
Accretion of convertible
debentures - 120,903 429,905
Loss on extinguishment of debt - - 782,143
Services received for common
shares - - 400,024
Write-off of investment - - 20,000
Interest expense paid in
common shares - - 140,032
-----------------------------------------------------------------------
(2,397,897) (1,217,579) (24,950,884)
Change in non-cash operating
working capital items 638,007 (110,711) 4,041,306
-----------------------------------------------------------------------
(1,759,890) (1,328,290) (20,909,578)
Financing activities:
Issue of shares, warrants and
units, net of issuance costs - - 38,281,778
Issuance of convertible bridge
loan, net
'/>"/>
| SOURCE ARIUS Research Inc. Copyright©2007 PR Newswire. All rights reserved |